Sara Mellid
Madrid, MD 28029, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Molecular profiling unveils genetic complexity and identifies potential new driver mechanisms in head and neck paragangliomas.
Journal: Genes & diseases
Published: November 04, 2024
Expression of Homo Sapiens (Hsa)-miR-139-5p as a Clinically Feasible Prognostic Marker for Differentiated Thyroid Cancer.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: October 28, 2024
MAML3-fusions modulate vascular and immune tumour microenvironment and confer high metastatic risk in pheochromocytoma and paraganglioma.
Journal: Best practice & research. Clinical endocrinology & metabolism
Published: September 01, 2024
Genetic bases of pheochromocytoma and paraganglioma.
Journal: Journal of molecular endocrinology
Published: December 01, 2022
Co-occurrence of mutations in NF1 and other susceptibility genes in pheochromocytoma and paraganglioma.
Journal: Frontiers in endocrinology
Published: October 14, 2022
DLST mutations in pheochromocytoma and paraganglioma cause proteome hyposuccinylation and metabolic remodeling.
Journal: Cancer communications (London, England)
Published: September 28, 2022
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition.
Journal: International journal of cancer
Published: June 03, 2022
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.
Journal: Nature communications
Published: May 05, 2022
Showing 1-11 of 11
Last Updated: 09/26/2026